MLTX - MoonLake Immunotherapeutics Stock Price, Fair Value and News

$13.36+0.84 (+6.71%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

MLTX Price Action

Last 7 days

-3.2%

Last 30 days

31.0%

Last 90 days

-77.6%

Trailing 12 Months

-74.0%

MLTX RSI Chart

MLTX Valuation

Market Cap

846.6M

Price/Earnings (Trailing)

-3.99

EV/EBITDA

-26.56

Price/Free Cashflow

-4.55

MarketCap/EBT

-5.55

MLTX Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

MLTX Fundamentals

MLTX Earnings

Earnings (TTM)

-211.9M

Earnings Growth (Yr)

-99.76%

Earnings Growth (Qtr)

-28.02%

MLTX Profitability

Return on Equity

-72.78%

Return on Assets

-51.15%

Free Cashflow Yield

-21.96%

MLTX Investor Care

Shares Dilution (1Y)

0.90%

Diluted EPS (TTM)

-3.32

Revenue & Growth

About MoonLake Immunotherapeutics

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or axial spondyloarthritis. MoonLake Immunotherapeutics was incorporated in 2021 and is headquartered in Zug, Switzerland.

CEO	Dr. Jorge Santos da Silva
WEBSITE	moonlaketx.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	20

MoonLake Immunotherapeutics Frequently Asked Questions

What is the ticker symbol for MoonLake Immunotherapeutics? What does MLTX stand for in stocks?

MLTX is the stock ticker symbol of MoonLake Immunotherapeutics. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of MoonLake Immunotherapeutics (MLTX)?

As of Wed Dec 03 2025, market cap of MoonLake Immunotherapeutics is 846.62 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MLTX stock?

You can check MLTX's fair value in chart for subscribers.

Is MoonLake Immunotherapeutics a good stock to buy?

The fair value guage provides a quick view whether MLTX is over valued or under valued. Whether MoonLake Immunotherapeutics is cheap or expensive depends on the assumptions which impact MoonLake Immunotherapeutics's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MLTX.